Reproductive Hormones and Proteins Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Reproductive Hormones and Proteins Tests Market Report Overview
The reproductive hormones and proteins tests market size was $119.1 million in 2023. The market is expected to grow at a CAGR of more than 1% during 2023-2033. Reproductive hormones and proteins assist in the control and regulation of physiological processes including metabolism, reproduction, and growth and development. They are secreted either from endocrine glands or from organs with secondary endocrine functions and affect the health and behavior of both males and females. Reproductive hormones and protein tests are performed to detect, measure, and monitor the presence of specific reproductive hormones and proteins in a patient’s sample.
Reproductive Hormones and Proteins Tests Market Outlook, 2023-2033 ($ Million)
Buy the Full Report for More Insights into the Reproductive Hormones and Proteins Tests Market Forecast
The reproductive hormones and proteins tests market research report has been created to understand market behavior, which will help identify quantitative market trends in the in vitro diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on the reproductive hormones and proteins tests market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing your in-licensing and out-licensing strategies.
Market Size (2023) | $119.1 million |
CAGR (2023-2033) | >1% |
Forecast Period | 2023-2033 |
Historical Period | 2015-2022 |
Key Segments | · Anti-Mullerian Hormone (AMH) Lab Tests
· Dehydroepiandrosterone Sulphate (DHEAS) Lab Tests · Estradiol Lab Tests · Follicle-Stimulating Hormone (FSH) Lab Tests · Luteinizing Hormone (LH) Lab Tests · Progesterone Lab Tests · Prolactin Lab Tests · Testosterone Lab Tests |
Key Regions | · North America
· Europe · Asia Pacific · South America · Middle East and Africa |
Leading Companies | · F. Hoffmann-La Roche Ltd
· Siemens Healthineers AG · Danaher Corp · Abbott Laboratories · Quidelortho Corp |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Reproductive Hormones and Proteins Tests Market Dynamics
Growth in the reproductive hormones and proteins tests market is expected to occur mainly in the North American, European, and APAC regions. Low or declining fertility rates and increased ART/IUI utilization rates are the main driving factors for the increased test sales. In some key markets such as the US and China, growth is also expected to be bolstered by recent regulatory approvals and increases in the associated medical infrastructure, respectively.
Reproductive Hormones and Proteins Tests Market Segments
The key segments in the reproductive hormones and proteins tests market are Anti-Mullerian Hormone (AMH) Lab Tests, Dehydroepiandrosterone Sulphate (DHEAS) Lab Tests, and Estradiol Lab Tests among others. Estradiol Lab Tests led the reproductive hormones and proteins tests market in 2023.
Estradiol hormone (E2) is an important female hormone mainly produced by the ovaries as well as by other organs or tissues such as the breast and adrenal glands. Estradiol is required to maintain reproductive functions. The hormone is also important for the growth and development of the breast, fallopian tubes, and uterus as well as for the health of bones and distribution of fat. In women, estradiol tests are performed to investigate infertility, menstrual disturbances, precocious puberty, menopausal symptoms, and cancer.
Reproductive Hormones and Proteins Tests Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Segment Insights into the Reproductive Hormones and Proteins Tests Market
Reproductive Hormones and Proteins Tests Market Segmentation by Regions
The key regions in the reproductive hormones and proteins tests market are North America, Europe, Asia Pacific, South America, and the Middle East and Africa. In 2023, North America accounted for the highest share of the reproductive hormones and proteins tests market. The US dominates the North American reproductive hormones and protein tests market and is expected to grow during the forecast period. Meanwhile, both the Canadian and Mexican markets are expected to remain steady.
Reproductive Hormones and Proteins Tests Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Reproductive Hormones and Proteins Tests Market
Reproductive Hormones and Proteins Tests Market - Competitive Landscape
A few of the leading companies in the reproductive hormones and proteins tests market are:
- Hoffmann-La Roche Ltd
- Siemens Healthineers AG
- Danaher Corp
- Abbott Laboratories
- Quidelortho Corp
Hoffmann-La Roche Ltd dominated the reproductive hormones and proteins tests market in 2023. Siemens Healthineers AG and Danaher Corp followed the lead among other reproductive hormones and protein tests market players.
Reproductive Hormones and Proteins Tests Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company Insights into the Reproductive Hormones and Proteins Tests Market
Segments Covered in the Report
Reproductive Hormones and Proteins Tests Segments Outlook (Value, $ Million, 2015-2033)
- Anti-Mullerian Hormone (AMH) Lab Tests
- Dehydroepiandrosterone Sulphate (DHEAS) Lab Tests
- Estradiol Lab Tests
- Follicle-Stimulating Hormone (FSH) Lab Tests
- Luteinizing Hormone (LH) Lab Tests
- Progesterone Lab Tests
- Prolactin Lab Tests
- Testosterone Lab Tests
Reproductive Hormones and Proteins Tests Regional Outlook (Value, $ Million, 2015-2033)
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Key Inclusions
Currently marketed Reproductive Hormones and Proteins Tests and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total Reproductive Hormones and Proteins Tests market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Reproductive Hormones and Proteins Tests market.
- Competitive dynamics insights and trends provided for the Reproductive Hormones and Proteins Tests market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Danaher Corp, Abbott Laboratories, Siemens AG, Quidelortho Corp, F. Hoffmann-La Roche Ltd, Tosoh Corp, and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This report provides:
- Insightful review of the key industry trends.
- Annualized total Reproductive Hormones and Proteins Tests market revenue by segment and market outlooks.
- Market-level data on units, average selling prices, and market values.
- Global, regional, and country-level market-specific insights including qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Reproductive Hormones and Proteins Tests market.
- Competitive dynamics insights and trends provided for the Reproductive Hormones and Proteins Tests market.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Reasons to Buy
The model will enable you to:
- Understand the impact of COVID-19 on the Reproductive Hormones and Proteins Tests market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Reproductive Hormones and Proteins Tests market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Reproductive Hormones and Proteins Tests market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific Reproductive Hormones and Proteins Tests market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Frequently asked questions
-
What was the reproductive hormones and proteins tests market size in 2023?
The reproductive hormones and proteins tests market size was $119.1 million in 2023.
-
What will the reproductive hormones and proteins tests market growth rate be during the forecast period?
The reproductive hormones and proteins tests market is expected to grow at a CAGR of more than 1% during 2023-2033.
-
Which region dominated the reproductive hormones and proteins tests market in 2023?
North America dominated the overall reproductive hormones and proteins tests market in 2023.
-
Which segment led the reproductive hormones and proteins tests market in 2023?
Estradiol Lab Tests led the reproductive hormones and proteins tests market in 2023.
-
Which are the leading companies in the reproductive hormones and proteins tests market?
A few of the leading companies in the reproductive hormones and proteins tests market are Beckman Coulter Inc., Abbott Laboratories, Siemens Healthineers AG, Ortho Clinical Diagnostics Holdings Plc, and Roche Diagnostics International Ltd, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.